Home > Products > Human Primary Cells >

Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated)

Product Name

Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated)

Price Get Quote
Cat.No

ABC-TC3008

Species

Human

Size/Quantity

1 vial

Biosafety Level

1

Shipping Info

Dry Ice

Storage

Liquid Nitrogen

Description

Acute Lymphoid Leukemia-PB-CD19+ B cells are positively isolated from adult Acute Lymphoid Leukemia peripheral blood Mononuclear Cells, using a direct immunomagnetic CD19 MicroBead labeling system. Acute Lymphoid Leukemia-PB-CD19+ B cells are available in the newly diagnosed and relapsed/refractory stages.

Disease

Acute Lymphoid Leukemia

Source Organ

Peripheral Blood

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Citation Guide

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

For research use only

Growth Conditions

37 ℃, 5% CO2

Cell Type

B Cell

Growth Mode

Suspension

Product Type

Immune Cells

Product Image AcceGen Frozen Cells & Cell Lines 1 vial
  • ONLINE INQUIRY
  • PRODUCT REVIEWS
We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time?

Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
Privacy Policy: AcceGen will never sell, rent, or share your personal information with any third parties without your express permission.
Reviews of Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated)
AcceGen is always trying to do right by our customers and working hard to build a higher quality product.

Your email address will not be published.

AcceGen Scroll Top Button
Copy link
Powered by Social Snap